Effective Component Compatibility of Bufei Yishen Formula III Which Regulates the Mucus Hypersecretion of COPD Rats via the miR‐146a‐5p/EGFR/MEK/ERK …
J Ma, X Liu, Y Wei, R Lu, K Xu… - … and Alternative Medicine, 2022 - Wiley Online Library
Background. The effective‐component compatibility of Bufei Yishen formula III (ECC‐BYF III)
with 5 ingredients (ginsenoside Rh1, astragaloside, icariin, nobiletin, and paeonol) has …
with 5 ingredients (ginsenoside Rh1, astragaloside, icariin, nobiletin, and paeonol) has …
Effective component compatibility of bufei yishen formula III which regulates the mucus hypersecretion of COPD rats via the miR-146a-5p/EGFR/MEK/ERK pathway.
J Ma, X Liu, Y Wei, R Lu, K Xu, Y Tian, J Li - 2022 - cabidigitallibrary.org
Background. The effective-component compatibility of Bufei Yishen formula III (ECC-BYF III)
with 5 ingredients (ginsenoside Rh1, astragaloside, icariin, nobiletin, and paeonol) has …
with 5 ingredients (ginsenoside Rh1, astragaloside, icariin, nobiletin, and paeonol) has …
Effective Component Compatibility of Bufei Yishen Formula III Which Regulates the Mucus Hypersecretion of COPD Rats via the miR-146a-5p/EGFR/MEK/ERK …
J Ma, X Liu, Y Wei, R Lu, K Xu, Y Tian… - … and Alternative Medicine …, 2022 - europepmc.org
Background The effective-component compatibility of Bufei Yishen formula III (ECC-BYF III)
with 5 ingredients (ginsenoside Rh1, astragaloside, icariin, nobiletin, and paeonol) has …
with 5 ingredients (ginsenoside Rh1, astragaloside, icariin, nobiletin, and paeonol) has …
[HTML][HTML] Effective Component Compatibility of Bufei Yishen Formula III Which Regulates the Mucus Hypersecretion of COPD Rats via the miR-146a-5p/EGFR/MEK …
J Ma, X Liu, Y Wei, R Lu, K Xu, Y Tian… - … and Alternative Medicine …, 2022 - ncbi.nlm.nih.gov
Background The effective-component compatibility of Bufei Yishen formula III (ECC-BYF III)
with 5 ingredients (ginsenoside Rh1, astragaloside, icariin, nobiletin, and paeonol) has …
with 5 ingredients (ginsenoside Rh1, astragaloside, icariin, nobiletin, and paeonol) has …
[PDF][PDF] Effective Component Compatibility of Bufei Yishen Formula III Which Regulates the Mucus Hypersecretion of COPD Rats via the miR-146a-5p/EGFR/MEK/ERK …
J Ma, X Liu, Y Wei, R Lu, K Xu, Y Tian, J Li - 2022 - scienceopen.com
Background. Te effective-component compatibility of Bufei Yishen formula III (ECC-BYF III)
with 5 ingredients (ginsenoside Rh1, astragaloside, icariin, nobiletin, and paeonol) has …
with 5 ingredients (ginsenoside Rh1, astragaloside, icariin, nobiletin, and paeonol) has …
Effective Component Compatibility of Bufei Yishen Formula III Which Regulates the Mucus Hypersecretion of COPD Rats via the miR-146a-5p/EGFR/MEK/ERK …
J Ma, X Liu, Y Wei, R Lu, K Xu… - Evidence-based …, 2022 - pubmed.ncbi.nlm.nih.gov
Background The effective-component compatibility of Bufei Yishen formula III (ECC-BYF III)
with 5 ingredients (ginsenoside Rh1, astragaloside, icariin, nobiletin, and paeonol) has …
with 5 ingredients (ginsenoside Rh1, astragaloside, icariin, nobiletin, and paeonol) has …
Effective Component Compatibility of Bufei Yishen Formula III Which Regulates the Mucus Hypersecretion of COPD Rats via the miR-146a-5p/EGFR/MEK/ERK …
J Ma, X Liu, Y Wei, R Lu, K Xu… - … & Alternative Medicine …, 2022 - search.ebscohost.com
Background. The effective-component compatibility of Bufei Yishen formula III (ECC-BYF III)
with 5 ingredients (ginsenoside Rh1, astragaloside, icariin, nobiletin, and paeonol) has …
with 5 ingredients (ginsenoside Rh1, astragaloside, icariin, nobiletin, and paeonol) has …
Effective Component Compatibility of Bufei Yishen Formula III Which Regulates the Mucus Hypersecretion of COPD Rats via the miR-146a-5p/EGFR/MEK/ERK …
J Ma, X Liu, Y Wei, R Lu, K Xu… - Evidence-Based …, 2022 - search.proquest.com
Background. The effective-component compatibility of Bufei Yishen formula III (ECC-BYF III)
with 5 ingredients (ginsenoside Rh1, astragaloside, icariin, nobiletin, and paeonol) has …
with 5 ingredients (ginsenoside Rh1, astragaloside, icariin, nobiletin, and paeonol) has …
Effective Component Compatibility of Bufei Yishen Formula III Which Regulates the Mucus Hypersecretion of COPD Rats via the miR-146a-5p/EGFR/MEK/ERK …
J Ma, X Liu, Y Wei, R Lu, K Xu, Y Tian… - … and Alternative Medicine …, 2022 - europepmc.org
Background The effective-component compatibility of Bufei Yishen formula III (ECC-BYF III)
with 5 ingredients (ginsenoside Rh1, astragaloside, icariin, nobiletin, and paeonol) has …
with 5 ingredients (ginsenoside Rh1, astragaloside, icariin, nobiletin, and paeonol) has …